尸体解剖时的人类大脑温度:死后生物化学指南

A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2018

Increased neural progenitors in individuals with cerebral small vessel disease.

Neuropathology and applied neurobiology·2011

An autoradiographic analysis of serotonin receptors in human temporal cortex: Changes in Alzheimer-type dementia.

Neurochemistry international·2010

Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex.

Neuroscience letters·2009

Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flow.

Neurobiology of aging·2009

Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.

Neurology·2007

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Pathological stratification and therapeutic implications for post-stroke depression based on a multidimensional biomarker panel: a narrative review.

Frontiers in neurology·2026

Imaging the neurohiv brain in animal models: past, present, and future-toward longitudinal, whole-brain aging phenotypes.

Frontiers in aging neuroscience·2026

Weight-adjusted-waist index, inflammation, and cognitive performance in older adults: a cross-sectional analysis from the Hordaland Health Study.

Frontiers in aging·2026

Cathepsin B Deficiency Attenuates Tau Spreading via Modulation of Proteasome Activity in Neurons.

Current neuropharmacology·2026

A Comprehensive Review on Compounds and Herbal Approaches against Amyloid Beta Aggregation in Alzheimer's Disease.

Central nervous system agents in medicinal chemistry·2026

Spatial heterogeneity of the ventricular interface between the median eminence and arcuate nucleus revealed by an unfolded whole-mount view.

Fluids and barriers of the CNS·2026

相关实验视频

尸体解剖时的人类大脑温度:死后生物化学指南

相关概念视频

A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age.

Increased neural progenitors in individuals with cerebral small vessel disease.

An autoradiographic analysis of serotonin receptors in human temporal cortex: Changes in Alzheimer-type dementia.

Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex.

Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flow.

Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Pathological stratification and therapeutic implications for post-stroke depression based on a multidimensional biomarker panel: a narrative review.

Imaging the neurohiv brain in animal models: past, present, and future-toward longitudinal, whole-brain aging phenotypes.

Weight-adjusted-waist index, inflammation, and cognitive performance in older adults: a cross-sectional analysis from the Hordaland Health Study.

Cathepsin B Deficiency Attenuates Tau Spreading via Modulation of Proteasome Activity in Neurons.

A Comprehensive Review on Compounds and Herbal Approaches against Amyloid Beta Aggregation in Alzheimer's Disease.

Spatial heterogeneity of the ventricular interface between the median eminence and arcuate nucleus revealed by an unfolded whole-mount view.

相关实验视频

尸体解剖时的人类大脑温度:死后生物化学指南

相关概念视频

相关文章